Reducing drug overdose for ex-prisoners -- the view from outside the prison gates

March 15, 2012

Prison inmates frequently have a strong history of drug use and misuse, especially during the time prior to incarceration, and drugs often are the driving force behind the offense itself. New research, published in BioMed Central's newly launched open access journal Addiction Science & Clinical Practice, shows that ex-offenders struggle to remain drug free after release from prison and identifies factors that can help them succeed. Interviews with former inmates show that they themselves recognize that returning to former living environments (former friends and an easy access to drugs) is a strong trigger for drug use and overdose.

Researchers from the University of Colorado School of Medicine and Kaiser Permanente Colorado interviewed former prisoners within two months of their release from prison. The interviews focused on experience of and alcohol use after release from prison, perception of risk of overdose, and experience of overdose amongst other ex-inmates.

Four main points came clearly across from these interviews. Return to was felt to be due to poor social support, or provided a way to cope with inadequate economic resources and health problems. Secondly, drugs were readily available in their living environment and a constant temptation. Studies based in the US have shown that there is a high risk of drug-related death after release from prison, and these ex-prisoners reported that while overdose was seen as a 'way out' in the face of overwhelming difficulties, accidental overdose, due to decreased drug tolerance, was also common. Finally, 'protective' factors including structured drug treatment programs, spirituality or religion, self-help groups, and family were identified as factors which strengthened them against relapse.

Dr Ingrid Binswanger, a Robert Wood Johnson Foundation Physician Faculty Scholar who led the study, summarized, "These interviews show that former inmates with a history of drug use, and criminal behavior related to their drug use, are often released back into environments with significant social and economic challenges, little support and readily available drugs. A consequence of this is a high risk of intentional and unintentional . These people need structured treatment, a gradual transition back into the community, and coping strategies. They also need access to 'protective' factors, as well as improved resources, to reduce the main triggers for relapse."

In the words of one ex-prisoner, "...the hardest thing is not going back to the lifestyle that got me put in prison."

Addiction Science & Clinical Practice, relaunched today with , publishes research dedicated to improving the quality of care for people with unhealthy alcohol, tobacco, and other drug use, or addictive behaviors.

Explore further: Physicians call for new approach to address national 'epidemic of mass incarceration'

More information: Return to drug use and overdose after release from prison: A qualitative study of risk and protective factors
Ingrid A Binswanger, Carolyn Nowels, Karen F Corsi, Jason Glanz, Jeremy Long, Robert E Booth and John F Steiner
Addiction Science & Clinical Practice (in press)

Related Stories

Recommended for you

Young adults found displaying symptoms of net addiction

October 17, 2014

In 2012, Allen Frances, MD, professor emeritus and former chair of the department of psychiatry at Duke University, cautioned that "Internet Addiction" could be the next new fad diagnosis, complete with "an exuberant trumpeting ...

Can 'love hormone' oxytocin protect against addiction?

March 19, 2014

(Medical Xpress)—Researchers at the University of Adelaide say addictive behaviour such as drug and alcohol abuse could be associated with poor development of the so-called "love hormone" system in our bodies during early ...

Nicotine vaccine prevents nicotine from reaching the brain

May 2, 2012

If smoking a cigarette no longer delivers pleasure, will smokers quit? It's the idea behind a nicotine vaccine being created by MIT and Harvard researchers, in which an injection of synthetic nanoparticles prompts the immune ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.